Related Experiment Video
Updated: Jun 4, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
PET Foils Functionalized with Reactive Copolymers as Adaptable Microvolume ELISA Spot Array Platforms for Multiplex
Sylwia Pniewska1,2, Marcin Drozd1,2, Alessandro Mussida3
1Department of Medical Diagnostics, Centre for Advanced Materials and Technologies CEZAMAT, Warsaw University of Technology, 02822 Warsaw, Poland.
New PET-based microvolume ELISA arrays offer sensitive and specific detection of COVID-19 biomarkers. These advanced diagnostic tools utilize novel surface chemistries for improved antibody detection in human serum.
Area of Science:
- Biomaterials Science
- Diagnostic Assay Development
- Immunotechnology
Background:
- Microvolume ELISA platforms are crucial for high-throughput diagnostics requiring minimal samples.
- Advanced substrate surfaces are essential for efficient biomolecule immobilization and antifouling properties, enhancing assay sensitivity and specificity.
Purpose of the Study:
- To develop and evaluate novel PET-based microvolume ELISA spot arrays for sensitive and specific antibody detection.
- To investigate the efficacy of amine- and DBCO-reactive copolymers for biomolecule immobilization and reduced non-specific binding.
Main Methods:
- Fabrication of PET microvolume ELISA spot arrays coated with MCP-2 and Copoly Azide copolymers.
- Covalent attachment of SARS-CoV-2 nucleoprotein (NP) for antibody immobilization.
- Validation using classical ELISA and Surface Plasmon Resonance (SPR) analysis.
- Clinical evaluation with human serum samples for anti-NP antibody detection.
Main Results:
- Covalent attachment demonstrated superior efficiency and reduced non-specific binding compared to passive adsorption.
- The arrays enabled sensitive detection of IgG and IgA antibodies, including IgG subclasses, in human serum.
- Clinical testing achieved 100.0% sensitivity and 92.9% specificity for anti-NP antibody detection in COVID-19 samples.
- DNA-directed immobilization facilitated multiplex serological measurements.
Conclusions:
- PET-based microvolume ELISA arrays with advanced surface coatings provide a scalable, high-throughput diagnostic solution.
- The platform demonstrates significant potential for sensitive and specific detection of multiple biomarkers, including COVID-19 antibodies.
- Integration into microfluidic devices is feasible, paving the way for advanced diagnostic applications.
More Related Videos
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
07:08A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021